Investorideas.com

Investorideas.com
Breaking News

Tuesday, November 21, 2017

Investorideas.com - #Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma

Investorideas.com - #Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma



Research
Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto
Rico



Vancouver, B.C. - November 21, 2017
(Investorideas.com Newswire) Veritas Pharma Inc.- Cannabis and Biopharma News
alert -  (
CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), ("Veritas" or the
"Company") reports  that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.

Investorideas.com Newswire - #Tech News: Gopher Protocol (OTCQB: $GOPH) Reports over $4 million in Revenue in 3rd Quarter Financials

Investorideas.com Newswire - #Tech News: Gopher Protocol (OTCQB: $GOPH) Reports over $4 million in Revenue in 3rd Quarter Financials



Gopher
Protocol Inc. (
OTCQB: GOPH) ("Gopher" or the "Company"),
a development-stage company which specializes in the creation of Internet of
Things (IoT) and Artificial Intelligence enabled mobile technologies, proudly
announces the release of its 3rd quarter financials on November 20, 2017.

Monday, November 20, 2017

Investorideas.com - New Entries and Money Flow into Bitcoin / Blockchain Market Creating New Levels for Bitcoin and Record Investor Enthusiasm

Investorideas.com - New Entries and Money Flow into Bitcoin / Blockchain Market Creating New Levels for Bitcoin and Record Investor Enthusiasm



Stocks
Mentioned: (TSXV: $HIVE.V), ( $OSTK), ( $MARA), ( $SQ), ( $CME),  ( $NDAQ)



Point Roberts, WA - November
20, 2017 -
Investorideas.com, a global investor news source covering leading sectors including
cryptocurrency and blockchain reports on recent entries into the bitcoin
/blockchain list of publicly-traded companies and the investor frenzy that has
seen bitcoin hit new highs following its recent sell-off.

Investorideas.com - Follow the Money in Artificial Intelligence and Robotics

Investorideas.com - Follow the Money in Artificial Intelligence and Robotics



Investorideas.com, a
global news source covering leading sectors including artificial Intelligence
and robotics issues a sector snapshot and video showcasing companies using the
technology, including Amazon.com
(NASDAQ: AMZN) . Square Capital (NYSE: SQ), Morgan Stanley (NYSE: MS), HSBC (NYSE: HSBC), Gopher Protocol Inc. (OTCQB: GOPH). 

 Follow the money in #AI &#Robotics -
 Watch the #Video

Investorideas.com - Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain

Investorideas.com - Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain



Veritas
Pharma Inc. (
CSE: VRT; OTC: VRTHF; and Frankfurt:
2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.



The
study will be done in two stages to assess the analgesic effects of this lead
strain. The first stage will have an open label design to look at the feasibility
of two doses of CTL-X in 5 subjects while the second stage will use a
randomized, double-blind, crossover design to assess one dose of CTL-X against
a placebo control strain in 16 subjects who will be exposed to various
modalities of acute pain.

Investorideas.com - Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain

Investorideas.com - Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto Rico to Begin Human Trials of Its Lead #Cannabis Strain for Pain



Veritas
Pharma Inc. (
CSE: VRT; OTC: VRTHF; and Frankfurt:
2VP), (“Veritas” or the “Company”) announces that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.



The
study will be done in two stages to assess the analgesic effects of this lead
strain. The first stage will have an open label design to look at the feasibility
of two doses of CTL-X in 5 subjects while the second stage will use a
randomized, double-blind, crossover design to assess one dose of CTL-X against
a placebo control strain in 16 subjects who will be exposed to various
modalities of acute pain.

Friday, November 17, 2017

Investorideas.com - ParcelPal (OTC: $PTNYF) (CSE: $PKG.CN) (FSE: $PT0) Expands Restaurant Offerings on Platform

Investorideas.com - ParcelPal (OTC: $PTNYF) (CSE: $PKG.CN) (FSE: $PT0) Expands Restaurant Offerings on Platform



ParcelPal Technology Inc. (OTC:
PTNYF) (CSE: PKG.CN) (FSE:PT0) ("ParcelPal" or the "Company) the
Vancouver based on demand delivery company is pleased to announce they have
further expanded the amount of restaurant offerings in downtown Vancouver by
adding another 50 restaurants to their platform.